Boundless Bio Inc (BOLD)
9.93
-0.03
(-0.30%)
USD |
NASDAQ |
May 17, 16:00
9.93
0.00 (0.00%)
After-Hours: 16:57
Boundless Bio Total Assets (Quarterly): 117.08M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 117.08M |
| December 31, 2023 | 129.89M |
| September 30, 2023 | 143.74M |
| Date | Value |
|---|---|
| June 30, 2023 | 154.93M |
| December 31, 2022 | 76.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
76.83M
Minimum
Dec 2022
154.93M
Maximum
Jun 2023
124.49M
Average
129.89M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Syra Health Corp | 4.552M |
| Adlai Nortye Ltd | 66.50M |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 258.26M |
| Shareholders Equity (Quarterly) | -141.18M |